000 01498 a2200421 4500
005 20250517150351.0
264 0 _c20180315
008 201803s 0 0 eng d
022 _a1740-7753
024 7 _a10.1177/1740774517697919
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPeterson, Ross L
245 0 0 _aAnalysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization.
_h[electronic resource]
260 _bClinical trials (London, England)
_cJun 2017
300 _a264-276 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlgorithms
650 0 4 _aData Interpretation, Statistical
650 0 4 _aHospitalization
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
_xtherapeutic use
650 0 4 _aInfluenza, Human
_xtherapy
650 0 4 _aMonte Carlo Method
650 0 4 _aProportional Hazards Models
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Outcome
700 1 _aVock, David M
700 1 _aPowers, John H
700 1 _aEmery, Sean
700 1 _aCruz, Eduardo Fernandez
700 1 _aHunsberger, Sally
700 1 _aJain, Mamta K
700 1 _aPett, Sarah
700 1 _aNeaton, James D
773 0 _tClinical trials (London, England)
_gvol. 14
_gno. 3
_gp. 264-276
856 4 0 _uhttps://doi.org/10.1177/1740774517697919
_zAvailable from publisher's website
999 _c27069416
_d27069416